- Role
- Country
- Date of registration
- Address
DE-MF-000013321nal von minden Drug-Screen® GHB 10 Test is an IVDD-legacy in vitro diagnostic registered in EUDAMED. It is classified as IVDD — General. Manufactured by nal von minden GmbH. Placed on the EU market in Germany. Explore certificates, regulatory status and the EUDAMED record on MD Atlas.
EUDAMED last updated this device on Jun 10, 2026
B-nvm-101089N-10UVPrimary DI
The Primary DI is the main UDI-DI a manufacturer designates as the principal identifier for a device in EUDAMED.
D-nvm-101089N-10UV
DataMatrix generation currently supports GS1-issued UDIs. HIBCC / ICCBBA support is coming.
1 warning recorded — scroll inside the panel to see all entries.
CW010Sterile
A sterile device is supplied free of viable micro-organisms — flagged so that it is handled, stored and used to preserve that sterile state.
Single-use device
A single-use device is intended to be used on one patient during a single procedure and then discarded — not reprocessed or reused.
Primary placement in Germany; available across 32 countries total.
| Country | On market since | Until |
|---|---|---|
| GermanyPrimary placement | — | Dec 31, 2029 |
| Austria | — | Dec 31, 2029 |
| Belgium | — | Dec 31, 2029 |
| Bulgaria | — | Dec 31, 2029 |
| Cyprus | — | Dec 31, 2029 |
| Czechia | — | Dec 31, 2029 |
| Denmark | — | Dec 31, 2029 |
| Estonia | — | Dec 31, 2029 |
| EL | — | Dec 31, 2029 |
| Spain | — | Dec 31, 2029 |
| Finland | — | Dec 31, 2029 |
| France | — | Dec 31, 2029 |
| Croatia | — | Dec 31, 2029 |
| Hungary | — | Dec 31, 2029 |
| Ireland | — | Dec 31, 2029 |
| Iceland | — | Dec 31, 2029 |
| Italy | — | Dec 31, 2029 |
| Liechtenstein | — | Dec 31, 2029 |
| Lithuania | — | Dec 31, 2029 |
| Luxembourg | — | Dec 31, 2029 |
| Latvia | — | Dec 31, 2029 |
| Malta | — | Dec 31, 2029 |
| Netherlands | — | Dec 31, 2029 |
| Norway | — | Dec 31, 2029 |
| Poland | — | Dec 31, 2029 |
| Portugal | — | Dec 31, 2029 |
| Romania | — | Dec 31, 2029 |
| Sweden | — | Dec 31, 2029 |
| Slovenia | — | Dec 31, 2029 |
| Slovakia | — | Dec 31, 2029 |
| Türkiye | — | Dec 31, 2029 |
| XI | — | Dec 31, 2029 |
Primary DI
The Primary DI is the main UDI-DI a manufacturer designates as the principal identifier for a device in EUDAMED.
D-nvm-101089N-10UVBasic UDI-DI
The Basic UDI-DI is the main identifier that groups together all device variants of the same model — the regulatory "family" key.
B-nvm-101089N-10UV101089N-10UDI issuing entities
Issuing entities are the organisations the European Commission has designated to assign Unique Device Identifiers under the EU's UDI system.
IVDR risk classes
IVDR risk classes rank in-vitro diagnostic devices from lowest risk (Class A) to highest (Class D), based on the patient and public-health risk of a wrong result.
European Medical Device Nomenclature — the EU product classification assigned to this device.
W0102160599DRUGS OF ABUSE/TOXICOLOGY RT & POC - OTHERB-nvm-102062Q9On the marketnal von minden Drug-Screen® FYL 10 TestB-nvm-101029Q4On the marketnal von minden Drug-Screen® FYL10 TestB-nvm-102029QBOn the marketnal von minden Drug-Screen® GHB 10 TestB-nvm-101089QNOn the marketnal von minden Drug-Screen® GHB 10 TestB-nvm-102089QVOn the marketnal von minden Drug-Screen® KET 1000 TestB-nvm-102024PZOn the marketNo certificate specifically references this device's Basic UDI-DI.
Certificate health across this manufacturer's portfolio.
IX 1034230-2IssuedNotified body
A notified body is an independent organisation, designated by an EU country, that audits manufacturers and certifies higher-risk devices before they can be CE-marked.
HX 1034230-1IssuedNotified body
A notified body is an independent organisation, designated by an EU country, that audits manufacturers and certifies higher-risk devices before they can be CE-marked.